Status:
COMPLETED
Blood Glucose Response of Processed Starch
Lead Sponsor:
INQUIS Clinical Research
Collaborating Sponsors:
University of Saskatchewan
Conditions:
Glycemic Response
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to determine the postprandial glycemic response of the two starches in humans. Participants will be asked to consume 2 test foods on 2 separate occasions and provide...
Detailed Description
Enrolled participants who are generally healthy and free of major chronic conditions will be randomized to receive either Commercial Native Starch or Extrusion Processed Starch first and then will be ...
Eligibility Criteria
Inclusion
- adult males or non-pregnant females.
- eligible to receive income in Canada.
Exclusion
- age less than 18 years
- any known food allergies or intolerances to the investigational product
- medications known to affect glucose tolerance -but stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable
- known history of diabetes mellitus or the use of anti-hyperglycemic drugs or insulin to treat diabetes and related conditions
- any major medical or surgical events requiring hospitalization within the preceding 3 months
- the presence of disease or drug(s) which influence digestion and absorption of nutrients
- the short-term use of systemic steroids or atypical antipsychotics (\<4 weeks) (all of which have major effects on glucose and metabolism and body fat distribution)
- any other medications or conditions which might, in the opinion of the Medical Director of INQUIS Clinical Research Ltd. (INQUIS), either 1) make participation dangerous to the subject or to others, or 2) affect the results
- any subject who cannot or will not comply with the experimental procedures or do not follow INQUIS safety guidelines
Key Trial Info
Start Date :
October 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06048978
Start Date
October 2 2023
End Date
November 30 2023
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
INQUIS Clinical Research Ltd.
Toronto, Ontario, Canada, M5C 2N8